Results 141 to 150 of about 284,307 (179)

Metastatic melanoma

, 2009
openaire   +1 more source

Idiosyncratic Drug-Induced Liver Injury in a Patient With Metastatic Melanoma. [PDF]

Cureus
Ottley A, Thornton A, Gil R, Sardinas G.
europepmc   +1 more source

ASO Author Reflections: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma. [PDF]

Ann Surg Oncol
Farooq MS, Shafique N, Karakousis GC.
europepmc   +1 more source

New-onset dermatomyositis in a patient on nivolumab for metastatic melanoma. [PDF]

BMJ Case Rep
Curkovic NB, Johnson DB, Parker ER.
europepmc   +1 more source

Exploring the impact of antibody-dependent cellular phagocytosis-related genes on the prognosis of metastatic melanoma. [PDF]

PLoS One
Chen J, He J, Xu X, Sun H, Zhang J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Metastatic melanoma

Current Treatment Options in Oncology, 2001
The overall survival for patients with metastatic melanoma ranges from 4.7 to 11 months, with a median survival of 8.5 months. Standard treatment for patients with metastatic melanoma has not been defined. The range of treatment options includes close observation, surgical resection of isolated metastases, therapy with dacarbazine, combination ...
W, Sun, L M, Schuchter
openaire   +2 more sources

Angiomatoid Metastatic Melanoma

Dermatologic Surgery, 2004
Two patients with metastatic melanoma, both with the same bizarre morphology and an unusual, comparatively benign course, are described: a 50-year-old female who more than 20 years after a primary melanoma on the right upper arm, Clark level III, maximum tumor thickness of 1.1 mm, developed multiple metastases in the deep soft tissue and a 62-year-old ...
Bettina G, Zelger, Bernhard, Zelger
openaire   +2 more sources